These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Matrix metalloproteinases in intestinal fibrosis. Biel C; Faber KN; Bank RA; Olinga P J Crohns Colitis; 2024 Mar; 18(3):462-478. PubMed ID: 37878770 [TBL] [Abstract][Full Text] [Related]
26. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis. Latella G; Viscido A Dig Dis Sci; 2020 May; 65(5):1299-1306. PubMed ID: 32124197 [TBL] [Abstract][Full Text] [Related]
27. Redox Imbalance in Intestinal Fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 Connection. Latella G Dig Dis Sci; 2018 Feb; 63(2):312-320. PubMed ID: 29273848 [TBL] [Abstract][Full Text] [Related]
28. Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs. Rodansky ES; Johnson LA; Huang S; Spence JR; Higgins PD Exp Mol Pathol; 2015 Jun; 98(3):346-51. PubMed ID: 25828392 [TBL] [Abstract][Full Text] [Related]
29. [Follow-up of pediatric inflammatory bowel disease]. Guan DX; Qiu XH; Ding ZL; Wang DY; Xu XW Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(28):1984-7. PubMed ID: 22944275 [TBL] [Abstract][Full Text] [Related]
30. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Sartor RB Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232 [TBL] [Abstract][Full Text] [Related]
31. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Lovisa S; Genovese G; Danese S J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951 [TBL] [Abstract][Full Text] [Related]
32. Molecular Basis of Intestinal Fibrosis in Inflammatory Bowel Disease. Andoh A; Nishida A Inflamm Intest Dis; 2023 Mar; 7(3-4):119-127. PubMed ID: 37064539 [TBL] [Abstract][Full Text] [Related]
33. Strictures in Crohn's Disease: From Pathophysiology to Treatment. Crespi M; Dulbecco P; De Ceglie A; Conio M Dig Dis Sci; 2020 Jul; 65(7):1904-1916. PubMed ID: 32279173 [TBL] [Abstract][Full Text] [Related]
34. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Apgar JT Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561 [TBL] [Abstract][Full Text] [Related]
35. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967 [TBL] [Abstract][Full Text] [Related]
36. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Wang J; Lin S; Brown JM; van Wagoner D; Fiocchi C; Rieder F Immunol Rev; 2021 Jul; 302(1):211-227. PubMed ID: 33993489 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. Schirbel A; Fiocchi C J Dig Dis; 2010 Oct; 11(5):266-76. PubMed ID: 20883422 [TBL] [Abstract][Full Text] [Related]
38. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Rieder F; Fiocchi C Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160 [TBL] [Abstract][Full Text] [Related]